

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | surfactant homeostasis (GO:0043129) | 5.58910755 |
| 2 | lymph vessel development (GO:0001945) | 4.53933359 |
| 3 | vascular endothelial growth factor signaling pathway (GO:0038084) | 4.50435484 |
| 4 | chemical homeostasis within a tissue (GO:0048875) | 4.48628411 |
| 5 | lymphangiogenesis (GO:0001946) | 4.26111600 |
| 6 | glomerular visceral epithelial cell development (GO:0072015) | 4.23351749 |
| 7 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 4.05925527 |
| 8 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.00724626 |
| 9 | renal filtration (GO:0097205) | 3.97618226 |
| 10 | glomerular epithelial cell development (GO:0072310) | 3.92087820 |
| 11 | glomerular basement membrane development (GO:0032836) | 3.89589296 |
| 12 | positive regulation of vasculogenesis (GO:2001214) | 3.84601617 |
| 13 | glomerular filtration (GO:0003094) | 3.83980638 |
| 14 | virion attachment to host cell (GO:0019062) | 3.83456796 |
| 15 | adhesion of symbiont to host cell (GO:0044650) | 3.83456796 |
| 16 | endothelium development (GO:0003158) | 3.80617398 |
| 17 | protein localization to endosome (GO:0036010) | 3.76202091 |
| 18 | regulation of vasculogenesis (GO:2001212) | 3.70303772 |
| 19 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.68450784 |
| 20 | adhesion of symbiont to host (GO:0044406) | 3.63282036 |
| 21 | blood vessel maturation (GO:0001955) | 3.61675559 |
| 22 | Golgi transport vesicle coating (GO:0048200) | 3.54977210 |
| 23 | COPI coating of Golgi vesicle (GO:0048205) | 3.54977210 |
| 24 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.54288804 |
| 25 | regulation of endothelial cell differentiation (GO:0045601) | 3.50625803 |
| 26 | barbed-end actin filament capping (GO:0051016) | 3.43828656 |
| 27 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.39973550 |
| 28 | protein retention in ER lumen (GO:0006621) | 3.30141432 |
| 29 | endothelial cell morphogenesis (GO:0001886) | 3.28599258 |
| 30 | protein carboxylation (GO:0018214) | 3.23662867 |
| 31 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.23662867 |
| 32 | negative regulation of cell size (GO:0045792) | 3.23613191 |
| 33 | NADH metabolic process (GO:0006734) | 3.22432388 |
| 34 | heart trabecula formation (GO:0060347) | 3.19684007 |
| 35 | adherens junction assembly (GO:0034333) | 3.18252193 |
| 36 | endothelial cell differentiation (GO:0045446) | 3.17366829 |
| 37 | axon ensheathment in central nervous system (GO:0032291) | 3.14348692 |
| 38 | central nervous system myelination (GO:0022010) | 3.14348692 |
| 39 | semaphorin-plexin signaling pathway (GO:0071526) | 3.12844632 |
| 40 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.12545614 |
| 41 | L-phenylalanine metabolic process (GO:0006558) | 3.12545614 |
| 42 | ethanol metabolic process (GO:0006067) | 3.11673534 |
| 43 | ethanol oxidation (GO:0006069) | 3.11577126 |
| 44 | protein maturation by protein folding (GO:0022417) | 3.08324332 |
| 45 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.07351926 |
| 46 | plasma membrane repair (GO:0001778) | 3.05033924 |
| 47 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.04222670 |
| 48 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.03310073 |
| 49 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 3.02114499 |
| 50 | creatine metabolic process (GO:0006600) | 2.99279333 |
| 51 | focal adhesion assembly (GO:0048041) | 2.98587422 |
| 52 | cell-substrate adherens junction assembly (GO:0007045) | 2.98587422 |
| 53 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.94676514 |
| 54 | axon ensheathment (GO:0008366) | 2.93767661 |
| 55 | ensheathment of neurons (GO:0007272) | 2.93767661 |
| 56 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.93704649 |
| 57 | regulation of plasminogen activation (GO:0010755) | 2.91410056 |
| 58 | extracellular fibril organization (GO:0043206) | 2.90506137 |
| 59 | epithelial cell-cell adhesion (GO:0090136) | 2.90091380 |
| 60 | sarcomere organization (GO:0045214) | 2.88479119 |
| 61 | myelination (GO:0042552) | 2.88321042 |
| 62 | primary alcohol catabolic process (GO:0034310) | 2.87627038 |
| 63 | cell-substrate junction assembly (GO:0007044) | 2.84507724 |
| 64 | atrioventricular valve morphogenesis (GO:0003181) | 2.84377150 |
| 65 | type B pancreatic cell proliferation (GO:0044342) | 2.84257744 |
| 66 | cardiac myofibril assembly (GO:0055003) | 2.81749502 |
| 67 | venous blood vessel morphogenesis (GO:0048845) | 2.80803071 |
| 68 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.80555628 |
| 69 | basement membrane organization (GO:0071711) | 2.79534612 |
| 70 | desmosome organization (GO:0002934) | 2.79044412 |
| 71 | negative regulation of protein localization to cell surface (GO:2000009) | 2.78068695 |
| 72 | regulation of cardioblast differentiation (GO:0051890) | 2.77084690 |
| 73 | endothelial tube morphogenesis (GO:0061154) | 2.75810431 |
| 74 | morphogenesis of an endothelium (GO:0003159) | 2.75810431 |
| 75 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.73735034 |
| 76 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.73735034 |
| 77 | skin morphogenesis (GO:0043589) | 2.73181460 |
| 78 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.73086070 |
| 79 | muscle cell migration (GO:0014812) | 2.71882740 |
| 80 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.71584533 |
| 81 | regulation of p38MAPK cascade (GO:1900744) | 2.70209519 |
| 82 | protein heterotrimerization (GO:0070208) | 2.68789701 |
| 83 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.68162189 |
| 84 | cell volume homeostasis (GO:0006884) | 2.67659353 |
| 85 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.64487536 |
| 86 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.64113791 |
| 87 | fibrinolysis (GO:0042730) | 2.63229623 |
| 88 | endothelial cell chemotaxis (GO:0035767) | 2.63210574 |
| 89 | regulation of actin filament-based movement (GO:1903115) | 2.62841532 |
| 90 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.62781495 |
| 91 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.61760706 |
| 92 | negative regulation of fatty acid transport (GO:2000192) | 2.61603275 |
| 93 | protein targeting to plasma membrane (GO:0072661) | 2.61239706 |
| 94 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 2.61214342 |
| 95 | transcytosis (GO:0045056) | 2.59937489 |
| 96 | myofibril assembly (GO:0030239) | 2.54929649 |
| 97 | regulation of cell communication by electrical coupling (GO:0010649) | 2.53426319 |
| 98 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.52131968 |
| 99 | regulation of axon guidance (GO:1902667) | 2.51341026 |
| 100 | proline biosynthetic process (GO:0006561) | 2.50890164 |
| 101 | positive regulation of receptor recycling (GO:0001921) | 2.50279229 |
| 102 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.49265329 |
| 103 | fibril organization (GO:0097435) | 2.48626879 |
| 104 | blood vessel endothelial cell migration (GO:0043534) | 2.48538780 |
| 105 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.47625092 |
| 106 | L-phenylalanine catabolic process (GO:0006559) | 2.47570123 |
| 107 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.47570123 |
| 108 | actin filament depolymerization (GO:0030042) | 2.47012745 |
| 109 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.46623103 |
| 110 | regulation of extracellular matrix disassembly (GO:0010715) | 2.46240792 |
| 111 | complement activation, alternative pathway (GO:0006957) | 2.46168751 |
| 112 | negative regulation of fibrinolysis (GO:0051918) | 2.45600262 |
| 113 | patterning of blood vessels (GO:0001569) | 2.43043478 |
| 114 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.38363099 |
| 115 | maternal placenta development (GO:0001893) | 2.38224988 |
| 116 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.37922538 |
| 117 | coronary vasculature morphogenesis (GO:0060977) | 2.37353126 |
| 118 | proline metabolic process (GO:0006560) | 2.36900247 |
| 119 | regulation of glomerular filtration (GO:0003093) | 2.36774602 |
| 120 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.35980433 |
| 121 | artery development (GO:0060840) | 2.35024416 |
| 122 | regulation of complement activation (GO:0030449) | 2.35018776 |
| 123 | regulation of protein activation cascade (GO:2000257) | 2.34790138 |
| 124 | regulation of fibrinolysis (GO:0051917) | 2.34109349 |
| 125 | fatty acid elongation (GO:0030497) | 2.32948256 |
| 126 | neuron remodeling (GO:0016322) | 2.31758832 |
| 127 | cell-cell junction maintenance (GO:0045217) | 2.31017416 |
| 128 | hemidesmosome assembly (GO:0031581) | 2.30278509 |
| 129 | cell communication involved in cardiac conduction (GO:0086065) | 2.29994284 |
| 130 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.29421209 |
| 131 | myelin maintenance (GO:0043217) | 2.28407595 |
| 132 | regulation of vascular permeability (GO:0043114) | 2.28344689 |
| 133 | trabecula formation (GO:0060343) | 2.28314156 |
| 134 | positive regulation of extracellular matrix organization (GO:1903055) | 2.27913273 |
| 135 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.27579682 |
| 136 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.27366462 |
| 137 | positive regulation of p38MAPK cascade (GO:1900745) | 2.27214674 |
| 138 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.26840954 |
| 139 | positive regulation of endothelial cell migration (GO:0010595) | 2.26158716 |
| 140 | cell migration involved in heart development (GO:0060973) | 2.25912520 |
| 141 | triglyceride catabolic process (GO:0019433) | 2.25462604 |
| 142 | actomyosin structure organization (GO:0031032) | 2.25372614 |
| 143 | cell adhesion mediated by integrin (GO:0033627) | 2.25308190 |
| 144 | apoptotic process involved in morphogenesis (GO:0060561) | 2.25266023 |
| 145 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.24181913 |
| 146 | epoxygenase P450 pathway (GO:0019373) | 2.23895817 |
| 147 | regulation of relaxation of muscle (GO:1901077) | 2.23509486 |
| 148 | response to water (GO:0009415) | 2.23080304 |
| 149 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.22994113 |
| 150 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.22743140 |
| 151 | stress fiber assembly (GO:0043149) | 2.22695533 |
| 152 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.22421483 |
| 153 | potassium ion import (GO:0010107) | 2.22401994 |
| 154 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.22380312 |
| 155 | urea metabolic process (GO:0019627) | 2.22187451 |
| 156 | fatty acid transmembrane transport (GO:1902001) | 2.22155988 |
| 157 | response to mercury ion (GO:0046689) | 2.21073043 |
| 158 | endocardial cushion development (GO:0003197) | 2.20936889 |
| 159 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.20430971 |
| 160 | myelination in peripheral nervous system (GO:0022011) | 2.19867423 |
| 161 | peripheral nervous system axon ensheathment (GO:0032292) | 2.19867423 |
| 162 | acylglycerol catabolic process (GO:0046464) | 2.19807987 |
| 163 | neutral lipid catabolic process (GO:0046461) | 2.19807987 |
| 164 | negative regulation of blood coagulation (GO:0030195) | 2.19797845 |
| 165 | negative regulation of hemostasis (GO:1900047) | 2.19797845 |
| 166 | regulation of blood vessel endothelial cell migration (GO:0043535) | 2.19736840 |
| 167 | metanephric epithelium development (GO:0072207) | 2.19396832 |
| 168 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.19214587 |
| 169 | cellular response to epinephrine stimulus (GO:0071872) | 2.19136904 |
| 170 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.18683678 |
| 171 | apoptotic cell clearance (GO:0043277) | 2.18650502 |
| 172 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.18484876 |
| 173 | camera-type eye morphogenesis (GO:0048593) | 2.17816463 |
| 174 | vasculogenesis (GO:0001570) | 2.17653955 |
| 175 | renal system process involved in regulation of blood volume (GO:0001977) | 2.17237537 |
| 176 | membrane assembly (GO:0071709) | 2.17163819 |
| 177 | 4-hydroxyproline metabolic process (GO:0019471) | 2.16678971 |
| 178 | blood vessel remodeling (GO:0001974) | 2.15647102 |
| 179 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.14856595 |
| 180 | metanephric nephron epithelium development (GO:0072243) | 2.14675001 |
| 181 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.14560024 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.40123094 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.26849972 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.26813078 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.26673449 |
| 5 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.45401289 |
| 6 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.41613657 |
| 7 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.26468329 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.12642017 |
| 9 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.08877853 |
| 10 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.07448081 |
| 11 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.97905028 |
| 12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.94218148 |
| 13 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.94218148 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.88215620 |
| 15 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.88109378 |
| 16 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.85118453 |
| 17 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.83124632 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.81069472 |
| 19 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.80798733 |
| 20 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.77774396 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.76473148 |
| 22 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.75448317 |
| 23 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.74298808 |
| 24 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.72520309 |
| 25 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.71448318 |
| 26 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.68729402 |
| 27 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.68729402 |
| 28 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.66676735 |
| 29 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.65780344 |
| 30 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.63597245 |
| 31 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.61068244 |
| 32 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.60993495 |
| 33 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.57923555 |
| 34 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.57277697 |
| 35 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.56883689 |
| 36 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.56502634 |
| 37 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.55728205 |
| 38 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.53506967 |
| 39 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.53476432 |
| 40 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.53389777 |
| 41 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.53139681 |
| 42 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.52918395 |
| 43 | * P68_20966046_ChIP-Seq_HELA_Human | 1.48686990 |
| 44 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.48449782 |
| 45 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.48389770 |
| 46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.47972763 |
| 47 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.46053152 |
| 48 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.45401237 |
| 49 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.45213418 |
| 50 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.42771179 |
| 51 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.41800760 |
| 52 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.41190779 |
| 53 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.40807313 |
| 54 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.39603358 |
| 55 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.38534285 |
| 56 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.37717809 |
| 57 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.37293257 |
| 58 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.36830572 |
| 59 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.36382855 |
| 60 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.34915354 |
| 61 | KDM2B_26808549_Chip-Seq_K562_Human | 1.34461964 |
| 62 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.33885835 |
| 63 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.33786263 |
| 64 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.33659385 |
| 65 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.32233329 |
| 66 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.31728325 |
| 67 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.31331067 |
| 68 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.31187238 |
| 69 | ATF3_27146783_Chip-Seq_COLON_Human | 1.29980631 |
| 70 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.29664646 |
| 71 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.29511832 |
| 72 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.28861352 |
| 73 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.28801846 |
| 74 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.28425687 |
| 75 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.28257637 |
| 76 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.28095239 |
| 77 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.28018867 |
| 78 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.25971458 |
| 79 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.24867140 |
| 80 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.24728513 |
| 81 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.23755472 |
| 82 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.23082126 |
| 83 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.18845868 |
| 84 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.18253875 |
| 85 | GATA1_19941826_ChIP-Seq_K562_Human | 1.17279596 |
| 86 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.17116978 |
| 87 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.16626036 |
| 88 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.16543313 |
| 89 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.16261439 |
| 90 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.15918417 |
| 91 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13982592 |
| 92 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13623912 |
| 93 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.12085990 |
| 94 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.12049907 |
| 95 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.11741421 |
| 96 | CJUN_26792858_Chip-Seq_BT549_Human | 1.11239333 |
| 97 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.10033657 |
| 98 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.09347328 |
| 99 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.08617090 |
| 100 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.06454962 |
| 101 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.06045106 |
| 102 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.05838277 |
| 103 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.05489177 |
| 104 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05353511 |
| 105 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.04623282 |
| 106 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.03563373 |
| 107 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.02865102 |
| 108 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01831338 |
| 109 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.01612120 |
| 110 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.01058263 |
| 111 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.01032153 |
| 112 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.00463550 |
| 113 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.00107771 |
| 114 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.00029731 |
| 115 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.99301116 |
| 116 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.99086252 |
| 117 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.98726069 |
| 118 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.98522497 |
| 119 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.98298632 |
| 120 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.98267135 |
| 121 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.97732597 |
| 122 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.97134096 |
| 123 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.95347810 |
| 124 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.95140342 |
| 125 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.94409317 |
| 126 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94390242 |
| 127 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.94259212 |
| 128 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.94198680 |
| 129 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.94152928 |
| 130 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.93522120 |
| 131 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.93033304 |
| 132 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.93027595 |
| 133 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.92996648 |
| 134 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.92351117 |
| 135 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.91569509 |
| 136 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.91125614 |
| 137 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.91125614 |
| 138 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.90797103 |
| 139 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.90260583 |
| 140 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.88154083 |
| 141 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.87955324 |
| 142 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87170205 |
| 143 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.87016032 |
| 144 | GATA1_22025678_ChIP-Seq_K562_Human | 0.86842993 |
| 145 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.86638774 |
| 146 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.86346705 |
| 147 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.85988421 |
| 148 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.85875131 |
| 149 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85760218 |
| 150 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.85753851 |
| 151 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.85573765 |
| 152 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.85507074 |
| 153 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.84288391 |
| 154 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.83288741 |
| 155 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.82985822 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010368_abnormal_lymphatic_system | 5.03982509 |
| 2 | MP0001879_abnormal_lymphatic_vessel | 4.05426753 |
| 3 | MP0005167_abnormal_blood-brain_barrier | 3.81188802 |
| 4 | MP0004084_abnormal_cardiac_muscle | 3.77442173 |
| 5 | MP0004272_abnormal_basement_membrane | 3.63105940 |
| 6 | MP0004036_abnormal_muscle_relaxation | 2.91008777 |
| 7 | MP0002837_dystrophic_cardiac_calcinosis | 2.74401801 |
| 8 | MP0000751_myopathy | 2.54352851 |
| 9 | MP0001958_emphysema | 2.51465545 |
| 10 | MP0006138_congestive_heart_failure | 2.41958754 |
| 11 | MP0010030_abnormal_orbit_morphology | 2.18862852 |
| 12 | MP0004215_abnormal_myocardial_fiber | 2.18136328 |
| 13 | MP0005623_abnormal_meninges_morphology | 2.13778278 |
| 14 | MP0005330_cardiomyopathy | 2.11979941 |
| 15 | MP0005503_abnormal_tendon_morphology | 2.09928726 |
| 16 | MP0008775_abnormal_heart_ventricle | 1.99905896 |
| 17 | MP0003950_abnormal_plasma_membrane | 1.99212575 |
| 18 | MP0003828_pulmonary_edema | 1.92571619 |
| 19 | MP0005360_urolithiasis | 1.88577973 |
| 20 | MP0005385_cardiovascular_system_phenoty | 1.82641323 |
| 21 | MP0001544_abnormal_cardiovascular_syste | 1.82641323 |
| 22 | MP0005257_abnormal_intraocular_pressure | 1.82070570 |
| 23 | MP0002972_abnormal_cardiac_muscle | 1.79790350 |
| 24 | MP0000749_muscle_degeneration | 1.76811195 |
| 25 | MP0009840_abnormal_foam_cell | 1.74872166 |
| 26 | MP0000920_abnormal_myelination | 1.73739567 |
| 27 | MP0004085_abnormal_heartbeat | 1.71860727 |
| 28 | MP0002295_abnormal_pulmonary_circulatio | 1.71077683 |
| 29 | MP0008438_abnormal_cutaneous_collagen | 1.66504842 |
| 30 | MP0004130_abnormal_muscle_cell | 1.65601223 |
| 31 | MP0003279_aneurysm | 1.63050719 |
| 32 | MP0004484_altered_response_of | 1.62121637 |
| 33 | MP0005165_increased_susceptibility_to | 1.61431543 |
| 34 | MP0004087_abnormal_muscle_fiber | 1.58643173 |
| 35 | MP0002249_abnormal_larynx_morphology | 1.55652453 |
| 36 | MP0002138_abnormal_hepatobiliary_system | 1.55041822 |
| 37 | MP0000767_abnormal_smooth_muscle | 1.54520602 |
| 38 | MP0005620_abnormal_muscle_contractility | 1.53180679 |
| 39 | MP0001849_ear_inflammation | 1.52616560 |
| 40 | MP0002877_abnormal_melanocyte_morpholog | 1.50285914 |
| 41 | MP0010630_abnormal_cardiac_muscle | 1.49334167 |
| 42 | MP0005451_abnormal_body_composition | 1.46285809 |
| 43 | MP0004510_myositis | 1.44136769 |
| 44 | MP0002796_impaired_skin_barrier | 1.42673755 |
| 45 | MP0004147_increased_porphyrin_level | 1.41718687 |
| 46 | MP0000747_muscle_weakness | 1.41540355 |
| 47 | MP0005058_abnormal_lysosome_morphology | 1.38582476 |
| 48 | MP0005595_abnormal_vascular_smooth | 1.37478854 |
| 49 | MP0005083_abnormal_biliary_tract | 1.36377964 |
| 50 | MP0000230_abnormal_systemic_arterial | 1.34826865 |
| 51 | MP0003137_abnormal_impulse_conducting | 1.34374364 |
| 52 | MP0010234_abnormal_vibrissa_follicle | 1.31184437 |
| 53 | MP0000343_altered_response_to | 1.26397486 |
| 54 | MP0000013_abnormal_adipose_tissue | 1.26347367 |
| 55 | MP0004782_abnormal_surfactant_physiolog | 1.26255959 |
| 56 | MP0004145_abnormal_muscle_electrophysio | 1.23287299 |
| 57 | MP0005023_abnormal_wound_healing | 1.23098295 |
| 58 | MP0003724_increased_susceptibility_to | 1.22038535 |
| 59 | MP0004185_abnormal_adipocyte_glucose | 1.21387636 |
| 60 | MP0000678_abnormal_parathyroid_gland | 1.20778896 |
| 61 | MP0000537_abnormal_urethra_morphology | 1.18748643 |
| 62 | MP0000750_abnormal_muscle_regeneration | 1.18503306 |
| 63 | MP0002060_abnormal_skin_morphology | 1.17558920 |
| 64 | MP0003690_abnormal_glial_cell | 1.17326623 |
| 65 | MP0000733_abnormal_muscle_development | 1.15888404 |
| 66 | MP0002896_abnormal_bone_mineralization | 1.15787220 |
| 67 | MP0002332_abnormal_exercise_endurance | 1.15713470 |
| 68 | MP0002128_abnormal_blood_circulation | 1.13982663 |
| 69 | MP0001542_abnormal_bone_strength | 1.13343142 |
| 70 | MP0005666_abnormal_adipose_tissue | 1.10167740 |
| 71 | MP0002139_abnormal_hepatobiliary_system | 1.09881781 |
| 72 | MP0002127_abnormal_cardiovascular_syste | 1.06551576 |
| 73 | MP0000249_abnormal_blood_vessel | 1.06448945 |
| 74 | MP0003705_abnormal_hypodermis_morpholog | 1.06233140 |
| 75 | MP0004885_abnormal_endolymph | 1.05658654 |
| 76 | MP0000534_abnormal_ureter_morphology | 1.04386965 |
| 77 | MP0005508_abnormal_skeleton_morphology | 1.03972713 |
| 78 | MP0002133_abnormal_respiratory_system | 1.02804187 |
| 79 | MP0005388_respiratory_system_phenotype | 1.02804187 |
| 80 | MP0000467_abnormal_esophagus_morphology | 1.01803079 |
| 81 | MP0004270_analgesia | 1.00153549 |
| 82 | MP0002269_muscular_atrophy | 0.99931245 |
| 83 | MP0005501_abnormal_skin_physiology | 0.99678435 |
| 84 | MP0003329_amyloid_beta_deposits | 0.98434172 |
| 85 | MP0003646_muscle_fatigue | 0.98183389 |
| 86 | MP0004043_abnormal_pH_regulation | 0.97286104 |
| 87 | MP0003566_abnormal_cell_adhesion | 0.97263575 |
| 88 | MP0000759_abnormal_skeletal_muscle | 0.95329110 |
| 89 | MP0000762_abnormal_tongue_morphology | 0.94946172 |
| 90 | MP0002106_abnormal_muscle_physiology | 0.94704466 |
| 91 | MP0005670_abnormal_white_adipose | 0.94362229 |
| 92 | MP0005332_abnormal_amino_acid | 0.93426394 |
| 93 | MP0009053_abnormal_anal_canal | 0.93261345 |
| 94 | MP0001614_abnormal_blood_vessel | 0.93105357 |
| 95 | MP0005365_abnormal_bile_salt | 0.93063702 |
| 96 | MP0002971_abnormal_brown_adipose | 0.92866701 |
| 97 | MP0002925_abnormal_cardiovascular_devel | 0.91382466 |
| 98 | MP0003191_abnormal_cellular_cholesterol | 0.91332017 |
| 99 | MP0005076_abnormal_cell_differentiation | 0.90912218 |
| 100 | MP0005375_adipose_tissue_phenotype | 0.90109239 |
| 101 | MP0003091_abnormal_cell_migration | 0.89750267 |
| 102 | MP0003453_abnormal_keratinocyte_physiol | 0.88878500 |
| 103 | MP0001756_abnormal_urination | 0.88376088 |
| 104 | MP0005164_abnormal_response_to | 0.87772212 |
| 105 | MP0005369_muscle_phenotype | 0.87691672 |
| 106 | MP0004233_abnormal_muscle_weight | 0.86397220 |
| 107 | MP0003634_abnormal_glial_cell | 0.85595032 |
| 108 | MP0009643_abnormal_urine_homeostasis | 0.85278123 |
| 109 | MP0002933_joint_inflammation | 0.81925392 |
| 110 | MP0000266_abnormal_heart_morphology | 0.80324908 |
| 111 | MP0003879_abnormal_hair_cell | 0.79489247 |
| 112 | MP0001661_extended_life_span | 0.78836432 |
| 113 | MP0002089_abnormal_postnatal_growth/wei | 0.78258357 |
| 114 | MP0008004_abnormal_stomach_pH | 0.78113752 |
| 115 | MP0003942_abnormal_urinary_system | 0.78017084 |
| 116 | MP0008875_abnormal_xenobiotic_pharmacok | 0.77545814 |
| 117 | MP0009384_cardiac_valve_regurgitation | 0.77013290 |
| 118 | MP0000858_altered_metastatic_potential | 0.76987429 |
| 119 | MP0000566_synostosis | 0.76034160 |
| 120 | MP0010329_abnormal_lipoprotein_level | 0.75185306 |
| 121 | MP0003221_abnormal_cardiomyocyte_apopto | 0.74780372 |
| 122 | MP0004883_abnormal_blood_vessel | 0.74735703 |
| 123 | MP0006054_spinal_hemorrhage | 0.74372774 |
| 124 | MP0005275_abnormal_skin_tensile | 0.72005303 |
| 125 | MP0002108_abnormal_muscle_morphology | 0.71676785 |
| 126 | MP0000003_abnormal_adipose_tissue | 0.71302381 |
| 127 | MP0002932_abnormal_joint_morphology | 0.70342185 |
| 128 | MP0001348_abnormal_lacrimal_gland | 0.69570761 |
| 129 | MP0003045_fibrosis | 0.69441416 |
| 130 | MP0000462_abnormal_digestive_system | 0.69074209 |
| 131 | MP0002970_abnormal_white_adipose | 0.69057207 |
| 132 | MP0009780_abnormal_chondrocyte_physiolo | 0.67842245 |
| 133 | MP0005409_darkened_coat_color | 0.66570705 |
| 134 | MP0003633_abnormal_nervous_system | 0.66552905 |
| 135 | MP0002118_abnormal_lipid_homeostasis | 0.63316778 |
| 136 | MP0001784_abnormal_fluid_regulation | 0.63198778 |
| 137 | MP0003075_altered_response_to | 0.62233123 |
| 138 | MP0005171_absent_coat_pigmentation | 0.61709830 |
| 139 | MP0004858_abnormal_nervous_system | 0.60137191 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 4.67556213 |
| 2 | Polycythemia (HP:0001901) | 4.44915391 |
| 3 | Muscle fiber splitting (HP:0003555) | 4.39020537 |
| 4 | Distal lower limb muscle weakness (HP:0009053) | 4.23783630 |
| 5 | Hyporeflexia of lower limbs (HP:0002600) | 4.21161591 |
| 6 | Cerebral hemorrhage (HP:0001342) | 4.12196225 |
| 7 | Broad metatarsal (HP:0001783) | 4.08619847 |
| 8 | Sudden death (HP:0001699) | 4.05578725 |
| 9 | Distal lower limb amyotrophy (HP:0008944) | 3.29560662 |
| 10 | Ventricular tachycardia (HP:0004756) | 3.27214348 |
| 11 | Hematochezia (HP:0002573) | 3.17663964 |
| 12 | Type 1 muscle fiber predominance (HP:0003803) | 3.17326205 |
| 13 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.14326440 |
| 14 | Hyperactive renin-angiotensin system (HP:0000841) | 3.13952697 |
| 15 | Hypokalemic alkalosis (HP:0001949) | 3.12386704 |
| 16 | Mesangial abnormality (HP:0001966) | 3.11083528 |
| 17 | Visceral angiomatosis (HP:0100761) | 3.10407547 |
| 18 | Atrial fibrillation (HP:0005110) | 3.07410499 |
| 19 | Difficulty running (HP:0009046) | 3.03912800 |
| 20 | Vertebral compression fractures (HP:0002953) | 2.98757098 |
| 21 | Spontaneous hematomas (HP:0007420) | 2.96659734 |
| 22 | Focal segmental glomerulosclerosis (HP:0000097) | 2.93685915 |
| 23 | Deep venous thrombosis (HP:0002625) | 2.87812352 |
| 24 | Exercise-induced myalgia (HP:0003738) | 2.87617208 |
| 25 | Hemangiomatosis (HP:0007461) | 2.82825954 |
| 26 | Neurofibrillary tangles (HP:0002185) | 2.82394066 |
| 27 | Right ventricular cardiomyopathy (HP:0011663) | 2.81664438 |
| 28 | Increased connective tissue (HP:0009025) | 2.81650809 |
| 29 | Abnormality of complement system (HP:0005339) | 2.80952442 |
| 30 | Lymphangioma (HP:0100764) | 2.80503302 |
| 31 | Calf muscle hypertrophy (HP:0008981) | 2.80189784 |
| 32 | Primary atrial arrhythmia (HP:0001692) | 2.80026051 |
| 33 | Exercise-induced muscle cramps (HP:0003710) | 2.79319010 |
| 34 | Upper limb amyotrophy (HP:0009129) | 2.79265301 |
| 35 | Distal upper limb amyotrophy (HP:0007149) | 2.79265301 |
| 36 | Vascular tortuosity (HP:0004948) | 2.77868554 |
| 37 | Renal salt wasting (HP:0000127) | 2.77200076 |
| 38 | Obstructive sleep apnea (HP:0002870) | 2.76659494 |
| 39 | Hemorrhage of the eye (HP:0011885) | 2.76574895 |
| 40 | Supraventricular arrhythmia (HP:0005115) | 2.75824556 |
| 41 | Cervical subluxation (HP:0003308) | 2.75726253 |
| 42 | Increased circulating renin level (HP:0000848) | 2.75034434 |
| 43 | Esophageal varix (HP:0002040) | 2.74237890 |
| 44 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.74050352 |
| 45 | Achilles tendon contracture (HP:0001771) | 2.72777359 |
| 46 | Abnormality of the Achilles tendon (HP:0005109) | 2.71088368 |
| 47 | Glomerulosclerosis (HP:0000096) | 2.70723816 |
| 48 | Increased variability in muscle fiber diameter (HP:0003557) | 2.70170055 |
| 49 | EMG: myopathic abnormalities (HP:0003458) | 2.64726662 |
| 50 | Supraventricular tachycardia (HP:0004755) | 2.64127197 |
| 51 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.63534311 |
| 52 | Fragile skin (HP:0001030) | 2.63299926 |
| 53 | Complement deficiency (HP:0004431) | 2.63137886 |
| 54 | Arterial tortuosity (HP:0005116) | 2.61109657 |
| 55 | Rapidly progressive (HP:0003678) | 2.60159863 |
| 56 | Myotonia (HP:0002486) | 2.59676809 |
| 57 | Prolonged QT interval (HP:0001657) | 2.56021452 |
| 58 | Short nail (HP:0001799) | 2.55501406 |
| 59 | J-shaped sella turcica (HP:0002680) | 2.53707466 |
| 60 | Aortic aneurysm (HP:0004942) | 2.53367092 |
| 61 | Broad face (HP:0000283) | 2.49847739 |
| 62 | Syncope (HP:0001279) | 2.47708199 |
| 63 | Acanthosis nigricans (HP:0000956) | 2.46991108 |
| 64 | Cerebral aneurysm (HP:0004944) | 2.42294745 |
| 65 | Interstitial pulmonary disease (HP:0006530) | 2.41952555 |
| 66 | Abnormality of the calf musculature (HP:0001430) | 2.39486083 |
| 67 | Pulmonary artery stenosis (HP:0004415) | 2.38182791 |
| 68 | Hypomagnesemia (HP:0002917) | 2.37174376 |
| 69 | Lipoatrophy (HP:0100578) | 2.35227809 |
| 70 | Axonal loss (HP:0003447) | 2.33557777 |
| 71 | Abnormality of renin-angiotensin system (HP:0000847) | 2.32094186 |
| 72 | Cavernous hemangioma (HP:0001048) | 2.31499443 |
| 73 | Hyperacusis (HP:0010780) | 2.31132099 |
| 74 | Facial shape deformation (HP:0011334) | 2.29949282 |
| 75 | Potter facies (HP:0002009) | 2.29949282 |
| 76 | Myoglobinuria (HP:0002913) | 2.29460799 |
| 77 | Hyperaldosteronism (HP:0000859) | 2.29283052 |
| 78 | Vascular calcification (HP:0004934) | 2.28034021 |
| 79 | Cardiovascular calcification (HP:0011915) | 2.27941186 |
| 80 | Lower limb amyotrophy (HP:0007210) | 2.27851592 |
| 81 | Muscle stiffness (HP:0003552) | 2.26738440 |
| 82 | Atrophic scars (HP:0001075) | 2.26570024 |
| 83 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.25365236 |
| 84 | Aortic dissection (HP:0002647) | 2.25271823 |
| 85 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.25173169 |
| 86 | Ulnar bowing (HP:0003031) | 2.21724675 |
| 87 | Wormian bones (HP:0002645) | 2.20859825 |
| 88 | Dilated cardiomyopathy (HP:0001644) | 2.20539948 |
| 89 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.19927114 |
| 90 | Blue sclerae (HP:0000592) | 2.19627423 |
| 91 | Generalized amyotrophy (HP:0003700) | 2.17672460 |
| 92 | Ankle contracture (HP:0006466) | 2.17373924 |
| 93 | Sensory axonal neuropathy (HP:0003390) | 2.16346149 |
| 94 | Joint stiffness (HP:0001387) | 2.15692374 |
| 95 | Cerebral inclusion bodies (HP:0100314) | 2.13199400 |
| 96 | Nonimmune hydrops fetalis (HP:0001790) | 2.12099005 |
| 97 | Foot dorsiflexor weakness (HP:0009027) | 2.12087826 |
| 98 | Back pain (HP:0003418) | 2.11181396 |
| 99 | Mitral stenosis (HP:0001718) | 2.10826391 |
| 100 | Mitral regurgitation (HP:0001653) | 2.10819092 |
| 101 | Hyperkalemia (HP:0002153) | 2.10035337 |
| 102 | Abnormality of chloride homeostasis (HP:0011422) | 2.08044713 |
| 103 | Spinal cord compression (HP:0002176) | 2.07913023 |
| 104 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.06160792 |
| 105 | Joint hemorrhage (HP:0005261) | 2.06153635 |
| 106 | Abnormality of magnesium homeostasis (HP:0004921) | 2.05580176 |
| 107 | Nuclear cataract (HP:0100018) | 2.05546329 |
| 108 | Growth hormone excess (HP:0000845) | 2.05458761 |
| 109 | Onion bulb formation (HP:0003383) | 2.04838346 |
| 110 | Bladder diverticulum (HP:0000015) | 2.04688671 |
| 111 | Neck muscle weakness (HP:0000467) | 2.04300846 |
| 112 | Glucose intolerance (HP:0000833) | 2.04129347 |
| 113 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.03627790 |
| 114 | Gout (HP:0001997) | 2.03370255 |
| 115 | Ventricular fibrillation (HP:0001663) | 2.03284792 |
| 116 | Pheochromocytoma (HP:0002666) | 2.02449342 |
| 117 | Abnormality of the nasal mucosa (HP:0000433) | 2.02190275 |
| 118 | Bundle branch block (HP:0011710) | 2.01928039 |
| 119 | Myopathic facies (HP:0002058) | 2.00611365 |
| 120 | Osteolytic defects of the hand bones (HP:0009699) | 1.99330086 |
| 121 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.99330086 |
| 122 | Palpitations (HP:0001962) | 1.99041253 |
| 123 | Hypoplasia of the iris (HP:0007676) | 1.98694123 |
| 124 | Bulbar palsy (HP:0001283) | 1.98457727 |
| 125 | Supranuclear gaze palsy (HP:0000605) | 1.95286416 |
| 126 | Venous abnormality (HP:0002624) | 1.95026984 |
| 127 | Abnormality of the foot musculature (HP:0001436) | 1.94313215 |
| 128 | Xanthomatosis (HP:0000991) | 1.93514267 |
| 129 | Shallow orbits (HP:0000586) | 1.93436477 |
| 130 | Long toe (HP:0010511) | 1.92943661 |
| 131 | Bronchomalacia (HP:0002780) | 1.91843668 |
| 132 | Difficulty climbing stairs (HP:0003551) | 1.91809913 |
| 133 | Biconcave vertebral bodies (HP:0004586) | 1.91073834 |
| 134 | Short hallux (HP:0010109) | 1.90079250 |
| 135 | Thin bony cortex (HP:0002753) | 1.88522744 |
| 136 | Atelectasis (HP:0100750) | 1.87623075 |
| 137 | Hand muscle atrophy (HP:0009130) | 1.87021349 |
| 138 | Ventricular arrhythmia (HP:0004308) | 1.85698671 |
| 139 | Hypoplastic left heart (HP:0004383) | 1.85409562 |
| 140 | Coxa vara (HP:0002812) | 1.84497249 |
| 141 | Respiratory distress (HP:0002098) | 1.83864349 |
| 142 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.83624842 |
| 143 | Hypertriglyceridemia (HP:0002155) | 1.81671933 |
| 144 | Elbow flexion contracture (HP:0002987) | 1.81637349 |
| 145 | Conjunctival telangiectasia (HP:0000524) | 1.81299135 |
| 146 | Atrioventricular block (HP:0001678) | 1.81153137 |
| 147 | Round ear (HP:0100830) | 1.81022548 |
| 148 | Tachypnea (HP:0002789) | 1.80998239 |
| 149 | Premature rupture of membranes (HP:0001788) | 1.80013623 |
| 150 | Heart block (HP:0012722) | 1.79660944 |
| 151 | Spinal rigidity (HP:0003306) | 1.79545827 |
| 152 | Systemic lupus erythematosus (HP:0002725) | 1.79217010 |
| 153 | Asymmetric septal hypertrophy (HP:0001670) | 1.77792706 |
| 154 | Ketoacidosis (HP:0001993) | 1.77743161 |
| 155 | Tubulointerstitial fibrosis (HP:0005576) | 1.76621872 |
| 156 | Flat acetabular roof (HP:0003180) | 1.76229956 |
| 157 | Aneurysm (HP:0002617) | 1.75142122 |
| 158 | Stridor (HP:0010307) | 1.74930088 |
| 159 | Testicular atrophy (HP:0000029) | 1.74151878 |
| 160 | Abnormality of dentin (HP:0010299) | 1.74002223 |
| 161 | Abnormal atrioventricular conduction (HP:0005150) | 1.73668096 |
| 162 | Insulin resistance (HP:0000855) | 1.71900220 |
| 163 | Skin nodule (HP:0200036) | 1.71211591 |
| 164 | Asymmetry of the thorax (HP:0001555) | 1.70167674 |
| 165 | Metabolic alkalosis (HP:0200114) | 1.68784479 |
| 166 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.67260035 |
| 167 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.67260035 |
| 168 | Scapular winging (HP:0003691) | 1.63887842 |
| 169 | Ulnar claw (HP:0001178) | 1.63846358 |
| 170 | Stage 5 chronic kidney disease (HP:0003774) | 1.62752612 |
| 171 | Nephritis (HP:0000123) | 1.61580333 |
| 172 | Adactyly (HP:0009776) | 1.60125685 |
| 173 | Neuroendocrine neoplasm (HP:0100634) | 1.58494078 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 7.15585734 |
| 2 | EPHA2 | 4.28420460 |
| 3 | STK39 | 4.27849756 |
| 4 | WNK4 | 3.55279158 |
| 5 | KDR | 3.43850804 |
| 6 | TESK1 | 3.28442991 |
| 7 | OXSR1 | 3.23921561 |
| 8 | MST1R | 2.62999447 |
| 9 | TGFBR2 | 2.48058805 |
| 10 | EPHB2 | 2.32272575 |
| 11 | EPHB1 | 2.23964332 |
| 12 | MYLK | 2.22364557 |
| 13 | IRAK3 | 2.07894285 |
| 14 | TTN | 2.00984193 |
| 15 | MAPKAPK3 | 1.87474920 |
| 16 | PHKG1 | 1.85889734 |
| 17 | PHKG2 | 1.85889734 |
| 18 | SMG1 | 1.78255313 |
| 19 | LMTK2 | 1.61927624 |
| 20 | FGFR2 | 1.61168814 |
| 21 | MET | 1.58275114 |
| 22 | ARAF | 1.56240624 |
| 23 | NME2 | 1.55944495 |
| 24 | WNK1 | 1.52108738 |
| 25 | RIPK1 | 1.50077840 |
| 26 | ICK | 1.42876272 |
| 27 | TRIB3 | 1.42858111 |
| 28 | PTK2B | 1.37442340 |
| 29 | BCR | 1.35274357 |
| 30 | EEF2K | 1.33067588 |
| 31 | ERN1 | 1.31789021 |
| 32 | NTRK1 | 1.27549928 |
| 33 | FER | 1.26384247 |
| 34 | DMPK | 1.25175225 |
| 35 | GRK1 | 1.24413509 |
| 36 | BCKDK | 1.23645289 |
| 37 | TESK2 | 1.18149416 |
| 38 | PRKD1 | 1.13715977 |
| 39 | KSR2 | 1.12015168 |
| 40 | PDGFRA | 1.10555521 |
| 41 | PAK6 | 1.10383015 |
| 42 | PDK2 | 1.09879827 |
| 43 | PRKD2 | 1.07819501 |
| 44 | PAK3 | 1.04284485 |
| 45 | RPS6KA2 | 1.00785051 |
| 46 | ROCK2 | 0.98633803 |
| 47 | PINK1 | 0.97672311 |
| 48 | LIMK1 | 0.97521580 |
| 49 | PTK6 | 0.92199310 |
| 50 | MAP3K3 | 0.88335297 |
| 51 | TAOK2 | 0.86831593 |
| 52 | STK38 | 0.85663332 |
| 53 | PDPK1 | 0.85112890 |
| 54 | TGFBR1 | 0.84227346 |
| 55 | CDK19 | 0.83493580 |
| 56 | MUSK | 0.83399196 |
| 57 | LRRK2 | 0.82465023 |
| 58 | ABL2 | 0.81490403 |
| 59 | PRKCH | 0.80687322 |
| 60 | CDC42BPA | 0.79798076 |
| 61 | MAP3K6 | 0.77861499 |
| 62 | MTOR | 0.77852640 |
| 63 | CAMK1G | 0.76896869 |
| 64 | RPS6KB2 | 0.76228502 |
| 65 | PKN1 | 0.75202170 |
| 66 | PAK4 | 0.74607626 |
| 67 | SCYL2 | 0.74299495 |
| 68 | PTK2 | 0.73996305 |
| 69 | ROCK1 | 0.73734509 |
| 70 | CAMK2D | 0.70796233 |
| 71 | OBSCN | 0.70731503 |
| 72 | PDGFRB | 0.67759334 |
| 73 | MAPK15 | 0.66905517 |
| 74 | TBK1 | 0.65331548 |
| 75 | PIM2 | 0.64898011 |
| 76 | RET | 0.64356756 |
| 77 | MAPK12 | 0.63997019 |
| 78 | PIK3CA | 0.63764505 |
| 79 | PKN2 | 0.61697615 |
| 80 | MARK2 | 0.61553701 |
| 81 | PRKG2 | 0.60587019 |
| 82 | HIPK2 | 0.59153478 |
| 83 | MAP3K1 | 0.58853826 |
| 84 | MOS | 0.58739598 |
| 85 | MAP2K2 | 0.58063578 |
| 86 | ILK | 0.58016845 |
| 87 | MAP3K2 | 0.57698836 |
| 88 | LATS2 | 0.57676916 |
| 89 | PDK4 | 0.57249172 |
| 90 | PDK3 | 0.57249172 |
| 91 | DDR2 | 0.56927487 |
| 92 | MAP3K9 | 0.56910209 |
| 93 | RPS6KL1 | 0.56895655 |
| 94 | RPS6KC1 | 0.56895655 |
| 95 | CSNK1A1L | 0.56495993 |
| 96 | MAP3K7 | 0.56448564 |
| 97 | CAMK2B | 0.55577782 |
| 98 | TYRO3 | 0.54468426 |
| 99 | FGFR4 | 0.54092997 |
| 100 | MAP3K12 | 0.53235643 |
| 101 | BMX | 0.52959142 |
| 102 | AKT2 | 0.52834269 |
| 103 | PRKCE | 0.51310777 |
| 104 | MAP2K1 | 0.50714252 |
| 105 | CAMK1D | 0.50295190 |
| 106 | CSNK1G3 | 0.50156262 |
| 107 | BRAF | 0.48844099 |
| 108 | PRKD3 | 0.47355681 |
| 109 | CAMK2G | 0.46800493 |
| 110 | GSK3A | 0.46680220 |
| 111 | DAPK3 | 0.46585496 |
| 112 | DAPK1 | 0.46257957 |
| 113 | DAPK2 | 0.46156374 |
| 114 | PRKAA2 | 0.45898257 |
| 115 | GRK5 | 0.45691498 |
| 116 | ERBB4 | 0.45077523 |
| 117 | PRKCI | 0.44782315 |
| 118 | FGR | 0.42755064 |
| 119 | EPHA3 | 0.42445825 |
| 120 | UHMK1 | 0.40706134 |
| 121 | CSNK1G2 | 0.40193887 |
| 122 | PAK2 | 0.40171636 |
| 123 | MAP2K3 | 0.39666406 |
| 124 | MAP3K11 | 0.39103230 |
| 125 | CSNK1G1 | 0.38809534 |
| 126 | RPS6KA6 | 0.38537336 |
| 127 | CSK | 0.38388182 |
| 128 | CAMK2A | 0.38288850 |
| 129 | PAK1 | 0.37718883 |
| 130 | PRPF4B | 0.37269955 |
| 131 | CDK5 | 0.36898034 |
| 132 | TRPM7 | 0.36349577 |
| 133 | INSRR | 0.36034588 |
| 134 | SRC | 0.34841541 |
| 135 | MAPKAPK2 | 0.34755696 |
| 136 | MAP3K13 | 0.34576151 |
| 137 | CDK14 | 0.34067916 |
| 138 | MAPK4 | 0.33749393 |
| 139 | SIK1 | 0.33693399 |
| 140 | IRAK2 | 0.32262196 |
| 141 | VRK2 | 0.31690150 |
| 142 | CDK8 | 0.31527975 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.89585877 |
| 2 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.05217514 |
| 3 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.04514286 |
| 4 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.01625117 |
| 5 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.99166533 |
| 6 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.98335498 |
| 7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.96091939 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.95956544 |
| 9 | Sulfur relay system_Homo sapiens_hsa04122 | 1.92820406 |
| 10 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.87904765 |
| 11 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.84425945 |
| 12 | Prion diseases_Homo sapiens_hsa05020 | 1.84160189 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.77387384 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.77233079 |
| 15 | Histidine metabolism_Homo sapiens_hsa00340 | 1.74606898 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.71791806 |
| 17 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.71523079 |
| 18 | Focal adhesion_Homo sapiens_hsa04510 | 1.60348022 |
| 19 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.58093962 |
| 20 | Axon guidance_Homo sapiens_hsa04360 | 1.55434425 |
| 21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.54947548 |
| 22 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.53515000 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.51780087 |
| 24 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.47973870 |
| 25 | Tight junction_Homo sapiens_hsa04530 | 1.44140029 |
| 26 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.40289156 |
| 27 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.34041339 |
| 28 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.32428146 |
| 29 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.31689781 |
| 30 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.30575584 |
| 31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.28088851 |
| 32 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.26683156 |
| 33 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.24288562 |
| 34 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.21192759 |
| 35 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.20166148 |
| 36 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.18060004 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.17856487 |
| 38 | Other glycan degradation_Homo sapiens_hsa00511 | 1.17476120 |
| 39 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.16255523 |
| 40 | Parkinsons disease_Homo sapiens_hsa05012 | 1.14790825 |
| 41 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.14561913 |
| 42 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.14365250 |
| 43 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.13751936 |
| 44 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.13464954 |
| 45 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.10187684 |
| 46 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.10092423 |
| 47 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.09785309 |
| 48 | Alzheimers disease_Homo sapiens_hsa05010 | 1.05556144 |
| 49 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.05407689 |
| 50 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.03011612 |
| 51 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.01362766 |
| 52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.00270583 |
| 53 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.99324270 |
| 54 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.98238133 |
| 55 | Galactose metabolism_Homo sapiens_hsa00052 | 0.97837178 |
| 56 | * Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.96521631 |
| 57 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.95854910 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.95260534 |
| 59 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.94712767 |
| 60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94203359 |
| 61 | Retinol metabolism_Homo sapiens_hsa00830 | 0.93980007 |
| 62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.93265171 |
| 63 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.92211595 |
| 64 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.91894203 |
| 65 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.91325357 |
| 66 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.91210312 |
| 67 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.90604112 |
| 68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.90249262 |
| 69 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.90248321 |
| 70 | Renin secretion_Homo sapiens_hsa04924 | 0.89526878 |
| 71 | Amoebiasis_Homo sapiens_hsa05146 | 0.89384812 |
| 72 | Gap junction_Homo sapiens_hsa04540 | 0.87759636 |
| 73 | Endocytosis_Homo sapiens_hsa04144 | 0.86596157 |
| 74 | Bladder cancer_Homo sapiens_hsa05219 | 0.85829517 |
| 75 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.85250694 |
| 76 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.85216560 |
| 77 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.83166183 |
| 78 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.82300643 |
| 79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81745454 |
| 80 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.80786393 |
| 81 | Salivary secretion_Homo sapiens_hsa04970 | 0.80682918 |
| 82 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.78558578 |
| 83 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.78235107 |
| 84 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.78054903 |
| 85 | Adherens junction_Homo sapiens_hsa04520 | 0.77573582 |
| 86 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.76125042 |
| 87 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.74616677 |
| 88 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.74408022 |
| 89 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.74023391 |
| 90 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.72974155 |
| 91 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.72141224 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71395271 |
| 93 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.71236556 |
| 94 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68041782 |
| 95 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.67973902 |
| 96 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.67625328 |
| 97 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.66774238 |
| 98 | Carbon metabolism_Homo sapiens_hsa01200 | 0.66616840 |
| 99 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.65843447 |
| 100 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.64394090 |
| 101 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.63136346 |
| 102 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.62642289 |
| 103 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.61620294 |
| 104 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.61595961 |
| 105 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.60772780 |
| 106 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.60524047 |
| 107 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.60025483 |
| 108 | Cocaine addiction_Homo sapiens_hsa05030 | 0.59128342 |
| 109 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.58799226 |
| 110 | Platelet activation_Homo sapiens_hsa04611 | 0.58396072 |
| 111 | Glioma_Homo sapiens_hsa05214 | 0.58358163 |
| 112 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58305066 |
| 113 | Peroxisome_Homo sapiens_hsa04146 | 0.57025226 |
| 114 | Mineral absorption_Homo sapiens_hsa04978 | 0.56726434 |
| 115 | Insulin resistance_Homo sapiens_hsa04931 | 0.56070648 |
| 116 | Taste transduction_Homo sapiens_hsa04742 | 0.55998047 |
| 117 | Circadian entrainment_Homo sapiens_hsa04713 | 0.55742439 |
| 118 | GABAergic synapse_Homo sapiens_hsa04727 | 0.54815628 |
| 119 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.52881519 |
| 120 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.52644768 |
| 121 | Insulin secretion_Homo sapiens_hsa04911 | 0.52480479 |
| 122 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.51685010 |
| 123 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51326055 |
| 124 | Viral myocarditis_Homo sapiens_hsa05416 | 0.50811515 |
| 125 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.50458678 |
| 126 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.50060630 |
| 127 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.50029091 |
| 128 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.49246849 |
| 129 | Melanogenesis_Homo sapiens_hsa04916 | 0.48930975 |
| 130 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.48777091 |
| 131 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.48276983 |
| 132 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48227485 |
| 133 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.48001872 |
| 134 | Thyroid cancer_Homo sapiens_hsa05216 | 0.47763964 |
| 135 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.47697602 |
| 136 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.47396438 |
| 137 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.47215484 |
| 138 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.46881286 |
| 139 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.46847043 |
| 140 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.46591131 |
| 141 | Endometrial cancer_Homo sapiens_hsa05213 | 0.46322547 |
| 142 | Morphine addiction_Homo sapiens_hsa05032 | 0.45599100 |
| 143 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45299189 |
| 144 | Huntingtons disease_Homo sapiens_hsa05016 | 0.44998496 |
| 145 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.43102442 |
| 146 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.40531042 |
| 147 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.40493117 |
| 148 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39993500 |

